FDA NDC Directory · JSON-LD · Markdown

Bupivacaine

NDC 57884-3252 · HUMAN PRESCRIPTION DRUG · INJECTION, SUSPENSION, LIPOSOMAL

Labeler / ManufacturerJiangsu Hengrui Pharmaceuticals Co., Ltd.
Marketing categoryAbbreviated NDA (generic) · App ANDA214348
Dosage form / routeINJECTION, SUSPENSION, LIPOSOMAL · INFILTRATION
Active ingredientsBUPIVACAINE (13.3 mg/mL)
Marketing started20240701
Package count1

External sources

Source: openFDA. Public-domain (CC0).